XML 24 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814
Business Segment Information - Summary of Net Margin by SBU Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Segment Reporting Information [Line Items]        
Total net margin $ 31,157 $ 34,728 $ 93,393 $ 100,356
General and administrative 19,348 19,322 63,423 55,396
Research and development 6,523 6,572 18,819 18,818
Restatements and related costs 1,147 2,326 9,276 12,959
Operating income 4,139 6,508 1,875 13,183
Operating Segments [Member] | BioStim [Member]        
Segment Reporting Information [Line Items]        
Total net margin 16,834 16,442 47,634 49,168
Operating Segments [Member] | Biologics [Member]        
Segment Reporting Information [Line Items]        
Total net margin 6,296 6,504 19,525 19,500
Operating Segments [Member] | Extremity Fixation [Member]        
Segment Reporting Information [Line Items]        
Total net margin 6,442 8,361 22,607 21,952
Operating Segments [Member] | Spine Fixation [Member]        
Segment Reporting Information [Line Items]        
Total net margin 1,938 3,958 4,582 11,147
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Total net margin (353) (537) (955) (1,411)
Material Reconciling Items [Member]        
Segment Reporting Information [Line Items]        
General and administrative 19,348 19,322 63,423 55,396
Research and development 6,523 6,572 18,819 18,818
Restatements and related costs $ 1,147 $ 2,326 $ 9,276 $ 12,959